Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years.
Thrombosis Research(2020)
摘要
•Very old age significantly influences treatment strategy in ITP.•Responses and disease complications are comparable in elderly and very elderly.•TRAs use may reduce risk of bleedings and infections in the elderly.•History of diabetes and thrombosis, but not TRAs use, increases thrombotic risk.
更多查看译文
关键词
ITP,Immune thrombocytopenia,Elderly,TPO-receptor agonists,Toxicity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络